608 related articles for article (PubMed ID: 9371826)
1. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).
Zhou Y; Xu BC; Maheshwari HG; He L; Reed M; Lozykowski M; Okada S; Cataldo L; Coschigamo K; Wagner TE; Baumann G; Kopchick JJ
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13215-20. PubMed ID: 9371826
[TBL] [Abstract][Full Text] [Related]
2. Generation of a miniature pig disease model for human Laron syndrome.
Cui D; Li F; Li Q; Li J; Zhao Y; Hu X; Zhang R; Li N
Sci Rep; 2015 Oct; 5():15603. PubMed ID: 26511035
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver.
Hinrichs A; Kessler B; Kurome M; Blutke A; Kemter E; Bernau M; Scholz AM; Rathkolb B; Renner S; Bultmann S; Leonhardt H; de Angelis MH; Nagashima H; Hoeflich A; Blum WF; Bidlingmaier M; Wanke R; Dahlhoff M; Wolf E
Mol Metab; 2018 May; 11():113-128. PubMed ID: 29678421
[TBL] [Abstract][Full Text] [Related]
4. Functional changes of the liver in the absence of growth hormone (GH) action - Proteomic and metabolomic insights from a GH receptor deficient pig model.
Riedel EO; Hinrichs A; Kemter E; Dahlhoff M; Backman M; Rathkolb B; Prehn C; Adamski J; Renner S; Blutke A; de Angelis MH; Bidlingmaier M; Schopohl J; Arnold GJ; Fröhlich T; Wolf E
Mol Metab; 2020 Jun; 36():100978. PubMed ID: 32277923
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of inherited growth hormone resistance in childhood.
Amselem S; Sobrier ML; Dastot F; Duquesnoy P; Duriez B; Goossens M
Baillieres Clin Endocrinol Metab; 1996 Jul; 10(3):353-69. PubMed ID: 8853444
[TBL] [Abstract][Full Text] [Related]
6. Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome.
Duquesnoy P; Sobrier ML; Amselem S; Goossens M
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10272-6. PubMed ID: 1719554
[TBL] [Abstract][Full Text] [Related]
7. Mouse models of growth hormone insensitivity.
Young J; Bell S; Qian Y; Hyman C; Berryman DE
Rev Endocr Metab Disord; 2021 Mar; 22(1):17-29. PubMed ID: 33037595
[TBL] [Abstract][Full Text] [Related]
8. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform.
Pantel J; Grulich-Henn J; Bettendorf M; Strasburger CJ; Heinrich U; Amselem S
J Clin Endocrinol Metab; 2003 Apr; 88(4):1705-10. PubMed ID: 12679461
[TBL] [Abstract][Full Text] [Related]
10. Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature.
Goddard AD; Dowd P; Chernausek S; Geffner M; Gertner J; Hintz R; Hopwood N; Kaplan S; Plotnick L; Rogol A; Rosenfield R; Saenger P; Mauras N; Hershkopf R; Angulo M; Attie K
J Pediatr; 1997 Jul; 131(1 Pt 2):S51-5. PubMed ID: 9255229
[TBL] [Abstract][Full Text] [Related]
11. Primary GH insensitivity '(Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I.
Besson A; Salemi S; Eblé A; Joncourt F; Gallati S; Jorge AA; Mullis PE
Eur J Endocrinol; 2004 May; 150(5):635-42. PubMed ID: 15132718
[TBL] [Abstract][Full Text] [Related]
12. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
[TBL] [Abstract][Full Text] [Related]
13. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration.
Jorge AA; Souza SC; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2004 Jan; 60(1):36-40. PubMed ID: 14678285
[TBL] [Abstract][Full Text] [Related]
14. Is the Laron mouse an accurate model of Laron syndrome?
Kopchick JJ; Laron Z
Mol Genet Metab; 1999 Oct; 68(2):232-6. PubMed ID: 10527674
[No Abstract] [Full Text] [Related]
15. Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling.
Zhang X; Mehta RG; Lantvit DD; Coschigano KT; Kopchick JJ; Green JE; Hedayat S; Christov KT; Ray VH; Unterman TG; Swanson SM
Carcinogenesis; 2007 Jan; 28(1):143-50. PubMed ID: 16916863
[TBL] [Abstract][Full Text] [Related]
16. Transgenic Wuzhishan minipigs designed to express a dominant-negative porcine growth hormone receptor display small stature and a perturbed insulin/IGF-1 pathway.
Li F; Li Y; Liu H; Zhang X; Liu C; Tian K; Bolund L; Dou H; Yang W; Yang H; Staunstrup NH; Du Y
Transgenic Res; 2015 Dec; 24(6):1029-42. PubMed ID: 26510874
[TBL] [Abstract][Full Text] [Related]
17. Growth Hormone Receptor Mutations Related to Individual Dwarfism.
Lin S; Li C; Li C; Zhang X
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29748515
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
[TBL] [Abstract][Full Text] [Related]
19. Absence of the plasma growth hormone-binding protein in Laron-type dwarfism.
Baumann G; Shaw MA; Winter RJ
J Clin Endocrinol Metab; 1987 Oct; 65(4):814-6. PubMed ID: 3654924
[TBL] [Abstract][Full Text] [Related]
20. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
